To many people’s way of thinking, the only way to achieve success in life is by playing it safe and sticking to the rules. However, there is no question that some of the greatest successes in the world wouldn’t have happened without at least some exposure to risk. When they are calculated, risks can be enormously beneficial in the world of business, and that is clearly evident in the life and career of Dr. Scott Rocklage. A graduate of the University of California at Berkeley and Massachusetts Institute of Technology, Rocklage now helps to bring innovative medical breakthroughs to reality as a managing partner of 5AM Ventures.
You don’t have to be familiar with the worlds of science, medicine and biopharmaceuticals to appreciate the incredible career of Dr. Scott Rocklage. Although he started out with plenty of advantages in life, the heights to which he has risen could not have been achieved without a great deal of hard work, perseverance and, again, a willingness to take risks from time to time. Given the trajectory of his education and career, it is clear that Rocklage knew what he needed to do from a very young age. In other words, he never squandered a moment of his time; he made every second count and learn more about Scott.
First, let’s take a look at Scott Rocklage’s educational achievements. He excelled in grade school and pushed himself hard all the way through his senior year of high school. All of the hard work paid off when he was accepted to the highly competitive University of California at Berkeley, where he graduated with a bachelor of science in chemistry four years later. Rocklage was so enamored of chemistry and the potential that it promised that he decided to further his education. He applied to and was accepted at the prestigious Massachusetts Institute of Technology’s graduate school. There, he studied under Nobel Prize winner Richard R. Schrock and gained a formidable background in chemistry and more information click here.
Initially, Scott Rocklage planned to devote himself to a career in chemistry. He started out in the chemical industry by serving as the leader of a small research team whose focus was to investigate a process called homogeneous catalysis. Although Rocklage enjoyed the work, he felt stifled and held back because he was limited to the research end of things. His innovative mind needed to be put to more effective use, and he felt that switching over to the business side of the science world was the way to go.
Dr. Scott Rocklage’s first foray into the business side of science occurred when he became the CEO of a company that specialized in MRI contrast agents. This position gave him invaluable experience in biopharmaceuticals as well as in life science venture investing. Rocklage came to realize that the best way for him to make a positive impact on the world was by helping companies get their ideas and innovations out to the public. Thanks to his unique understanding of chemistry and the chemical industry as well as his incredible business acumen, Rocklage has emerged as one of the most effective venture capitalists in this area.
Before looking at the work that Scott Rocklage accomplishes with 5AM Ventures, the venture capital firm where he serves as a managing partner, let’s take a look at his many business connections. Rocklage is one of those people who is never content to just sit around being satisfied with how things are. As a result, he gets involved with all kinds of organizations and efforts. For example, he currently serves on the boards of Pulmatrix, EPIRUS and Achaogen. He also serves as board chairman of Relypsa, Kinstral, K2, Novira and Rennovia.
As a managing partner at 5AM Ventures, Scott Rocklage helps to promote untraditional approaches to diagnosing, treating and preventing various medical conditions. Rocklage came on board with 5AM Ventures in 2003 as a venture partner; the following year, he moved over to being a managing partner. Rocklage has always been a natural fit for the work, given that he is named as inventor or co-inventor on more than 30 U.S. patents and that he has published more than 100 peer-reviewed papers. He also has substantial healthcare management experience and was instrumental in the FDA approval of three U.S. New Drug Applications for Cubicin, Teslascan and Omniscan.
As busy as he may be with his business interests, Scott Rocklage understands the importance of maintaining a healthy work-life balance. He and his wife Patty, a successful therapist, split their time between homes in metro Boston and Florida. The couple enjoys playing golf, and they are very close to their three adult children. At just 61 years of age, Scott Rocklage more than likely won’t fully retire for a long time. Whenever he does, though, you can be sure that he won’t be sitting around doing nothing and Scott’s lacrosse camp.